IDBS Celebrated as the Best Bioprocessing Supplier at ABEA 2025
In a remarkable display of innovation and excellence, IDBS has secured the prestigious
Best Bioprocessing Supplier Award: Software at the
Asia-Pacific Biopharma Excellence Awards (ABEA) 2025. This honor reflects IDBS's commitment to driving advancements within the biopharma sector, particularly in cloud software solutions tailored for BioPharma companies.
The recognition highlights IDBS's significant contributions to improving processes in biopharmaceutical manufacturing and logistics. The award was determined by an extensive evaluation process, which included votes from over 10,000 industry professionals, evaluating more than 500 entries and involving 150+ companies across 50+ countries. This level of scrutiny underscores the esteemed nature of the award and the high standards set within the industry.
The Importance of the ABEA Awards
The Asia-Pacific Biopharma Excellence Awards serve as a platform to celebrate outstanding achievements in bioprocessing, logistics, supply chain management, antibody-drug conjugates (ADC), and clinical trials. By recognizing the exceptional work of leaders in the field, the ABEA awards acknowledge not only current achievements but also aim to inspire future innovations. The gala event took place on
March 12, 2025, at the
Sands Expo and Convention Centre in Singapore, attracting over 1,300 industry leaders and pioneers.
This year’s awards were held in conjunction with several key events, including the
12th Annual Biologics Manufacturing Asia 2025,
Biologistics World Asia, and the
Clinical Trial Festival Asia, further cementing the significance of this gathering in the biopharma calendar.
Quotes from Leadership
Expressing his enthusiasm,
Pietro Forgione, General Manager of IDBS, stated,
“We are incredibly honored to receive this award. This recognition from our industry peers highlights the dedication of our team to advancing digitalization within biologics. We are committed to continuing our efforts to provide innovative solutions that enhance quality and efficiency for our customers.”
IDBS has consistently positioned itself as a trusted partner for over 80% of the top 20 global BioPharma companies, leveraging their 35 years of scientific informatics expertise. The company's flagship product,
IDBS E-WorkBook, and its
IDBS Polar and
PIMS cloud platforms are examples of their dedication to deliver scalable and flexible solutions supporting the crucial phases of a product’s lifecycle, from R&D through to manufacturing.
Looking Ahead
As a pioneer in biopharmaceutical software solutions, IDBS aims to further expand its influence in the industry. The accolades received at such high-profile award ceremonies not only affirm their current market position but also set the vision for future developments. Moving forward, IDBS continues to unlock the potential of
AI/ML within biopharma, striving to enhance the quality of patient care through innovative technological solutions.
For more insights into IDBS and its latest innovations, visit their official website at
idbs.com.